InflaRx IFRX
NASDAQ IFRX
$2.05 -0.04 (-1.91%)
As of: Sep 10, 2026 · 3:59 PM EDT

InflaRx (IFRX) Other Operating Expenses (2016 - 2026)

InflaRx's (IFRX) quarterly Other Operating Expenses came in at -$35073.1 in Q2 2026, up 96.94% year-over-year from -$17808.8 in Q2 2025, and up 72.28% quarter-over-quarter from -$126524.8 in Q1 2026.

Analysis

InflaRx (IFRX) Other Operating Expenses (2016 - 2026) Analysis & Trends

InflaRx has disclosed Other Operating Expenses across 11 years of filings, most recently posting -$35073.1 for Q2 2026.

  • In Q2 2026, Other Operating Expenses rose 96.94% year-over-year to -$35073.1; the TTM figure through Jun 2026 stood at -$1.5 million (up 66.44% YoY), while the FY2020 annual figure was -$61245.9 billion, down 7901870346.72% from the prior year.
  • Other Operating Expenses came in at -$35073.1 for Q2 2026 at InflaRx, up from -$126524.8 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of -$1.01 in Q3 2022 to a low of -$53456.5 billion in Q4 2022.
  • Average Other Operating Expenses over 5 years is -$4859.7 billion, with a median of -$1.5 million recorded in 2025.
  • Year-over-year, Other Operating Expenses tumbled 54131316000.0% in 2022 and soared 96.94% in 2026.
  • Over 5 years, Other Operating Expenses stood at -$53456.5 billion in 2022, then soared by 100.0% to -$1.7 million in 2023, then dropped by 10.26% to -$1.9 million in 2024, then gained by 27.1% to -$1.4 million in 2025, then soared by 97.43% to -$35073.1 in 2026.
  • Per Business Quant data, the three most recent Other Operating Expenses figures were -$35073.1 in Q2 2026, -$126524.8 in Q1 2026, and -$1.4 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 InflaRx 139.29 Mn -44.96 Mn 2.74 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -35,073.11
Mar 31, 2026 -126,524.82
Sep 30, 2025 -1.37 Mn
Jun 30, 2025 -1.15 Mn
Mar 31, 2025 -1.53 Mn
Sep 30, 2024 -1.88 Mn
Mar 31, 2024 -1.59 Mn
Sep 30, 2023 -1.70 Mn
Dec 31, 2022 -53,456.47 Bn
Sep 30, 2022 -1.01
Jun 30, 2022 -23.86 Mn
Dec 31, 2021 -54,547.52 Bn
Sep 30, 2021 0.00
Jun 30, 2021 -27.21 Mn
Mar 31, 2021 -1.21
Dec 31, 2020 -30,622.91 Bn
Mar 31, 2020 1.10
Dec 31, 2019 0.01
Jun 30, 2019 0.00
Dec 31, 2018 -199,123.45